THC Farmaceuticals, Inc.
CBDG
$0.08
$0.06277.36%
OTC PK
| 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | |
|---|---|---|---|---|---|
| Net Income | -730.23% | -444.44% | 40.14% | -95.45% | 18.87% |
| Total Depreciation and Amortization | 0.00% | 100.00% | 0.00% | 0.00% | -33.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -48,425.00% | -510.53% | -155.00% | -- | 3.70% |
| Cash from Operations | -107,761.54% | -584.62% | -614.29% | 41.86% | 40.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1,276.00% | 3,869.50% | 2,903.33% | -72.73% | -28.57% |
| Total Debt Repaid | -- | -455.56% | -7,977.78% | 100.00% | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 32,760.00% | 5,056.82% | 728.57% | -65.71% | -3.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48,491.67% | 291,450.00% | -- | -85.71% | 200.00% |